Laparoscopic sentinel lymph node versus hyperextensive pelvic dissection for staging clinically localized prostate carcinoma: A prospective study of 200 patients

Journal of Nuclear Medicine

Volumn 55, Issue 5, 2014, Pages 753-758

  Rousseau, Caroline ^a,b   Rousseau, Thierry ^c   Campion, Loïc ^a   Lacoste, Jacques ^c   Aillet, Geneviéve ^d   Potiron, Eric ^c   Lacombe, Marie ^a   Coguic, Georges Le ^c   Mathieu, Cédric ^a   Kraeber Bodéré, Françoise ^a,b,e  

^a UMR INSERM U892 CNRS 6299   (France)

^b Team 12   (France)

^c Urologic Clinic Nantes Atlantis   (France)

^d Institut d'Histopathologie   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Hyperextended pelvic lymph node dissection; Laparoscopic surgery; Prostate cancer; Sentinel lymph node

Indexed keywords

RHENIUM SULFIDE COLLOID TC 99M;

ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; EX VIVO STUDY; EXTERNAL BEAM RADIOTHERAPY; FALSE NEGATIVE RESULT; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HYPEREXTENSIVE PELVIC DISSECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTERMETHOD COMPARISON; LAPAROSCOPIC SENTINEL SYMPH NODE DISSECTION; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CARCINOMA; PROSTATECTOMY; SENTINEL LYMPH NODE METASTASIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL APPROACH; TUMOR INVASION; VALIDATION PROCESS;

HYPEREXTENDED PELVIC LYMPH NODE DISSECTION; LAPAROSCOPIC SURGERY; PROSTATE CANCER; SENTINEL LYMPH NODE;

ADULT; AGED; CARCINOMA; FALSE NEGATIVE REACTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOSCINTIGRAPHY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM; ULTRASONOGRAPHY;

EID: 84901359870     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.129023     Document Type: Article

References (34)

1. Bubendorf L, Schöpfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31:578-583.
2. Cheng L, Zincke H, Blute M, Bergstralh E, Scherer B, Bostwick D. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer. 2001;91:66-73.
3. Heidenreich A, Aus G, Bolla M, et al. EAU guidelines on prostate cancer. Eur Urol. 2008;53:68-80.
4. Briganti A, Chun FK, Salonia A, et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol. 2006;50:1006-1013.
5. Masterson TA, Bianco FJ Jr., Vickers AJ, et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol. 2006;175:1320-1324.
6. Briganti A, Chun FK, Salonia A, et al. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Urology. 2007;69:147-151.
7. Heidenreich A, Ohlmann CH, Polyakov S. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur Urol. 2007;52:29-37.
8. Van Baelen A, Mottet N, Spahn M, Briganti A, Gontero P, Joniau S. Sense and nonsense of an extended pelvic lymph node dissection in prostate cancer. Adv Urol. 2012; 2012: 983058.
9. Glass EC, Essner R, Giuliano AE. Sentinel node localization in breast cancer. Semin Nucl Med. 1999;29:57-68.
10. Wawroschek F, Vogt H, Weckermann D, Wagner T, Harzmann R. The sentinel lymph node concept in prostate cancer: first results of gamma probe-guided sentinel lymph node identification. Eur Urol. 1999;36:595-600.
11. Wawroschek F, Vogt H, Weckermann D, Wagner T, Hamm M, Harzmann R. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol. 2001;166:1715-1719.
12. Briganti A, Larcher A, Abdollah F, et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol. 2012;61:480-487.
13. D'Amico AV, Whittington R, Malkowicz SB, Tomaszewski JE, Schultz D, Wein A. Outcome based staging for clinically localized adenocarcinoma of the prostate. J Urol. 1997;158:1422-1426.
14. Rousseau C, Rousseau T, Bridji B, et al. Laparoscopic sentinel lymph node (SLN) versus extensive pelvic dissection for clinically localized prostate carcinoma. Eur J Nucl Med Mol Imaging. 2012;39:291-299.
15. Rousseau T, Lacoste J, Pallardy A, et al. Laparoscopic sentinel lymph node (SLN) dissection for clinically localized prostate carcinoma: results obtained in the first 70 patients. Prog Urol. 2012;22:30-37.
16. Lécuru F, Mathevet P, Querleu D, et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol. 2011;29:1686-1691.
17. Cagiannos I, Karakiewicz P, Eastham JA, et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol. 2003;170:1798-1803.
18. Jeschke S, Nambirajan T, Leeb K, Ziegerhofer J, Sega W, Janetschek G. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol. 2005;173:1943-1946.
19. Häcker A, Jeschke S, Leeb K, et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol. 2006;176:2014-2018.
20. Corvin S, Schilling D, Eichhorn K, et al. Laparoscopic sentinel lymph node dissection: a novel technique for the staging of prostate cancer. Eur Urol. 2006;49:280-285.
21. Warncke SH, Mattei A, Fuechsel FG. Z'Brun S, Krause T, Studer UE. Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol. 2007;52:126-132.
22. Meinhardt W, Valdés Olmos RA, van der Poel HG, Bex A, Horenblas S. Laparoscopic sentinel node dissection for prostate carcinoma: technical and anatomical observations. BJU Int. 2008;102:714-717.
23. Jeschke S, Beri A, Grüll M, et al. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol. 2008;53:126-132.
24. Vermeeren L, Valdés Olmos RA, Meinhardt W, et al. Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med. 2009;50: 865-870.
25. Schilling D, Boekeler U, Gakis G, et al. Modified concept for radioisotope-guided sentinel lymph node dissection in prostate cancer. World J Urol. 2010;28:715-720.
26. Vermeeren L, Muller SH, Meinhardt W, Valdés Olmos RA. Optimizing the colloid concentration for improved preoperative and intraoperative image-guided detection of sentinel nodes in prostate cancer. Eur J Nucl Med Mol Imaging. 2010;37:1328-1334.
27. Joniau S, Van den Bergh L, Lerut E, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. 2013;63:450-458.
28. Eiriksson LR, Covens A. Sentinel lymph node mapping in cervical cancer: the future? BJOG. 2012;119:129-133.
29. Winter A, Kneib T, Henke RP, Wawroschek F. Sentinel lymph node dissection in more than 1200 prostate cancer cases: Rate and prediction of lymph node involvement depending on preoperative tumor characteristics. Int J Urol. 2014;21:58-63.
30. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol. 2011;59:61-71.
31. Jeschke S, Lusuardi L, Myatt A, Hruby S, Pirich C, Janetschek G. Visualisation of the lymph node pathway in real time by laparoscopic radioisotope-and fluorescence-guided sentinel lymph node dissection in prostate cancer staging. Urology. 2012;80:1080-1086.
32. Fujisawa M, Miyake H. Significance of micrometastases in prostate cancer. Surg Oncol. 2008;17:247-252.
33. Chéreau E, Bezu C, Gligorov J, et al. Impact of immunohistochemical analysis of sentinel lymph node biopsy on breast cancer management. Anticancer Res. 2012;32:3403-3409.
34. Weckermann D, Dorn R, Trefz M, Wagner T, Wawroschek F, Harzmann R. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. J Urol. 2007;177:916-920.